Peptide Library

In clinical trials

Digestive & weight

Amycretin

Evidence

Clinical trials

Class

Dual amylin and GLP-1 receptor agonist

/

Amycretin

KEY TAKEAWAY

Amycretin is a single molecule designed to activate both the amylin receptor and the GLP-1 receptor. Novo Nordisk is developing it for obesity and type 2 diabetes. Amycretin is not FDA-approved and is being tested in clinical trials, in both injected and oral forms.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Dual amylin and GLP-1 receptor agonist

Being studied for

Studied for obesity and type 2 diabetes

Key fact

Amycretin is not FDA-approved and is being tested in clinical trials, in both injected and oral forms.

Route

Injection and oral tablet in trials

Evidence strength

Clinical trials

What it is

What it is

Amycretin is a single molecule designed to activate both the amylin receptor and the GLP-1 receptor. Novo Nordisk is developing it for obesity and type 2 diabetes.

How it works

How it works

It combines the effect of GLP-1 on appetite and insulin with the effect of amylin on fullness.

Regulatory status

Regulatory status

Amycretin is not FDA-approved and is being tested in clinical trials, in both injected and oral forms.

What it is used for

What it is used for

Studied for obesity and type 2 diabetes.

Side effects and risks

Side effects and risks

Nausea and vomiting were the most commonly reported effects in early trials.

Citations

Citations

Amycretin: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo